OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
Giacomo Caldarola, Federico Pirrò, Alessandro Di Stefani, et al.
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 6, pp. 665-672
Closed Access | Times Cited: 70
Giacomo Caldarola, Federico Pirrò, Alessandro Di Stefani, et al.
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 6, pp. 665-672
Closed Access | Times Cited: 70
Showing 51-75 of 70 citing articles:
Treatment with an interleukin‐17 inhibitor resulted in complete remission of psoriasis and flare‐up of atopic dermatitis
Naoko Hattori, Yuta Koike, Hiroyuki Murota
The Journal of Dermatology (2022) Vol. 49, Iss. 5
Closed Access | Times Cited: 3
Naoko Hattori, Yuta Koike, Hiroyuki Murota
The Journal of Dermatology (2022) Vol. 49, Iss. 5
Closed Access | Times Cited: 3
Secukinumab‐induced scar sarcoidosis in a patient with plaque psoriasis
Nika Hlača, Tina Žagar, Marija Kaštelan, et al.
Australasian Journal of Dermatology (2022) Vol. 63, Iss. 2
Closed Access | Times Cited: 3
Nika Hlača, Tina Žagar, Marija Kaštelan, et al.
Australasian Journal of Dermatology (2022) Vol. 63, Iss. 2
Closed Access | Times Cited: 3
A case of eczematous eruption occurring during treatment with risankizumab
Eleonora De Luca, Giacomo Caldarola, Alessandro Di Stefani, et al.
Italian Journal of Dermatology and Venereology (2023) Vol. 158, Iss. 1
Closed Access | Times Cited: 1
Eleonora De Luca, Giacomo Caldarola, Alessandro Di Stefani, et al.
Italian Journal of Dermatology and Venereology (2023) Vol. 158, Iss. 1
Closed Access | Times Cited: 1
Development of a sebo-psoriasis-like dermatosis: a newly paradoxical reaction due to ixekizumab described with line-field confocal optical coherence tomography
Francesca FALCINELLI, Laura Lazzeri, Linda TOGNETTI, et al.
Italian Journal of Dermatology and Venereology (2023) Vol. 159, Iss. 2
Closed Access | Times Cited: 1
Francesca FALCINELLI, Laura Lazzeri, Linda TOGNETTI, et al.
Italian Journal of Dermatology and Venereology (2023) Vol. 159, Iss. 2
Closed Access | Times Cited: 1
Reacciones cutáneas (no paradójicas) inducidas por tratamientos biológicos
Ofelia Baniandrés, C. Ciudad‐Blanco
Piel (2024) Vol. 39, Iss. 5, pp. 270-278
Closed Access
Ofelia Baniandrés, C. Ciudad‐Blanco
Piel (2024) Vol. 39, Iss. 5, pp. 270-278
Closed Access
A Case of Paradoxical Acneiform Eruption Triggered by Ixekizumab
Fidan BENER
Turkiye Klinikleri Journal of Case Reports (2024) Vol. 32, Iss. 2, pp. 32-35
Open Access
Fidan BENER
Turkiye Klinikleri Journal of Case Reports (2024) Vol. 32, Iss. 2, pp. 32-35
Open Access
Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab
Gennaro Marco Falco, Giacomo Caldarola, Alessandra D’Amore, et al.
Skin Health and Disease (2024) Vol. 4, Iss. 5
Open Access
Gennaro Marco Falco, Giacomo Caldarola, Alessandra D’Amore, et al.
Skin Health and Disease (2024) Vol. 4, Iss. 5
Open Access
Electrostimulation: A Promising New Treatment for Psoriasis
Zhuo Zuo, Ya Xing Wang, Yanwei Fang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13005-13005
Open Access
Zhuo Zuo, Ya Xing Wang, Yanwei Fang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13005-13005
Open Access
Infective dermatitis after treatment with secukinumab
Thaís Oliveira Utiyama, Cristiano A. F. Zerbini, Gabriel Guimarães
Clinical and Experimental Dermatology (2021) Vol. 47, Iss. 1, pp. 151-153
Closed Access | Times Cited: 3
Thaís Oliveira Utiyama, Cristiano A. F. Zerbini, Gabriel Guimarães
Clinical and Experimental Dermatology (2021) Vol. 47, Iss. 1, pp. 151-153
Closed Access | Times Cited: 3
Cutaneous adverse effects of biologic drugs in psoriasis: a literature review
Špela Šuler Baglama, Katarina Trčko
Acta Dermatovenerologica Alpina Pannonica et Adriatica (2021) Vol. 30, Iss. 4
Closed Access | Times Cited: 3
Špela Šuler Baglama, Katarina Trčko
Acta Dermatovenerologica Alpina Pannonica et Adriatica (2021) Vol. 30, Iss. 4
Closed Access | Times Cited: 3
Eczéma induit par les anti-IL-17 et le yin-yang Th2/Th17
Alessia Nidegger, Raphael Jenelten, Curdin Conrad
Revue Médicale Suisse (2022) Vol. 18, Iss. 775, pp. 574-577
Open Access | Times Cited: 2
Alessia Nidegger, Raphael Jenelten, Curdin Conrad
Revue Médicale Suisse (2022) Vol. 18, Iss. 775, pp. 574-577
Open Access | Times Cited: 2
Eczematous Reactions Induced by Anti-IL17 Agents
Alba Sánchez‐Velázquez, Daniel Falkenhain‐López, Alba López Valle, et al.
Indian Journal of Dermatology (2022) Vol. 67, Iss. 3, pp. 307-308
Open Access | Times Cited: 2
Alba Sánchez‐Velázquez, Daniel Falkenhain‐López, Alba López Valle, et al.
Indian Journal of Dermatology (2022) Vol. 67, Iss. 3, pp. 307-308
Open Access | Times Cited: 2
Allergic Contact Dermatitis Mimicking Anti–Interleukin 17 Eczematous Eruption
A. Casanova‐Esquembre, Javier Lorca-Spröhnle, Carolina Labrandero-Hoyos, et al.
Dermatitis (2022) Vol. 34, Iss. 5, pp. 464-465
Closed Access | Times Cited: 1
A. Casanova‐Esquembre, Javier Lorca-Spröhnle, Carolina Labrandero-Hoyos, et al.
Dermatitis (2022) Vol. 34, Iss. 5, pp. 464-465
Closed Access | Times Cited: 1
Eczematous drug eruptions mostly manageable with emollients and corticosteroids
Caroline Fenton, Connie Kang
Drugs & Therapy Perspectives (2021) Vol. 38, Iss. 1, pp. 13-18
Closed Access | Times Cited: 1
Caroline Fenton, Connie Kang
Drugs & Therapy Perspectives (2021) Vol. 38, Iss. 1, pp. 13-18
Closed Access | Times Cited: 1
Generalized Eczematous Eruption after Secukinumab Treatment Successfully Treated with Dupilumab and Guselkum
Claudia Paganini
Clinical Dermatology Open Access Journal (2023) Vol. 8, Iss. 3, pp. 1-3
Open Access
Claudia Paganini
Clinical Dermatology Open Access Journal (2023) Vol. 8, Iss. 3, pp. 1-3
Open Access
A case of Atopic Eczema-like Paradoxical Eruption in a patient with Psoriasis Receiving Secukinumab
Dong Sung Kim, Ki Dam Kim, Jae Young Heo, et al.
Daehan geonseon hakoeji (Online) (2023) Vol. 20, Iss. 1, pp. 35-38
Open Access
Dong Sung Kim, Ki Dam Kim, Jae Young Heo, et al.
Daehan geonseon hakoeji (Online) (2023) Vol. 20, Iss. 1, pp. 35-38
Open Access
Implication of T Helper Cytokines in Contact Dermatitis and Atopic Dermatitis
Perrine Cochez, Mathilde Choteau, Nisha Limaye, et al.
Current Treatment Options in Allergy (2020) Vol. 7, Iss. 3, pp. 258-273
Closed Access
Perrine Cochez, Mathilde Choteau, Nisha Limaye, et al.
Current Treatment Options in Allergy (2020) Vol. 7, Iss. 3, pp. 258-273
Closed Access
Psoriasis: talking points from recent clinical trials
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 12, pp. 1265-1267
Closed Access
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 12, pp. 1265-1267
Closed Access
Author reply to: Comment on: ‘Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?’
Angelo Ruggiero, Matteo Megna, Giuseppina Caiazzo, et al.
Clinical and Experimental Dermatology (2022) Vol. 48, Iss. 4, pp. 396-397
Closed Access
Angelo Ruggiero, Matteo Megna, Giuseppina Caiazzo, et al.
Clinical and Experimental Dermatology (2022) Vol. 48, Iss. 4, pp. 396-397
Closed Access
